CSIMarket


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd

PPBT's Fundamental analysis








Purple Biotech Ltd 's sales fell in IV. Quarter 2022 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.82 %

Purple Biotech Ltd 's net income grew by 17.83 % in IV. Quarter 2022 year on year, above company average,

More on PPBT's Growth


Purple Biotech Ltd
achieved net income of 22 millions in the past twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.


More on PPBT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Purple Biotech Ltd
achieved net income of 22 millions in the past twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.